Pharmhouse Corp (PHSE) - Net Assets
Based on the latest financial reports, Pharmhouse Corp (PHSE) has net assets worth $54.93 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($63.16 Million) and total liabilities ($8.23 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how large is Pharmhouse Corp's balance sheet for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $54.93 Million |
| % of Total Assets | 86.97% |
| Annual Growth Rate | 7.51% |
| 5-Year Change | 707.73% |
| 10-Year Change | 922937.24% |
| Growth Volatility | 18761.76 |
Pharmhouse Corp - Net Assets Trend (1996–2025)
This chart illustrates how Pharmhouse Corp's net assets have evolved over time, based on quarterly financial data. Check Pharmhouse Corp tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Pharmhouse Corp (1996–2025)
The table below shows the annual net assets of Pharmhouse Corp from 1996 to 2025. For live valuation and market cap data, see PHSE stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $52.30 Million | +5309.87% |
| 2024-12-31 | $-1.00 Million | -324.39% |
| 2023-12-31 | $-236.54K | -106.72% |
| 2022-12-31 | $3.52 Million | -45.60% |
| 2021-12-31 | $6.47 Million | +1.74% |
| 2020-12-31 | $6.36 Million | +32431.48% |
| 2019-12-31 | $-19.68K | -7.62% |
| 2018-12-31 | $-18.29K | -4.93% |
| 2017-12-31 | $-17.43K | -407.62% |
| 2015-12-31 | $5.67K | +56616.72% |
| 2014-12-31 | $9.99 | -100.00% |
| 1998-12-31 | $570.54K | -83.87% |
| 1997-12-31 | $3.54 Million | -44.83% |
| 1996-12-31 | $6.41 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Pharmhouse Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4184.6% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $3.87 Million | 7.40% |
| Other Comprehensive Income | $136.82K | 0.26% |
| Other Components | $72.24 Million | 138.12% |
| Total Equity | $52.30 Million | 100.00% |
Pharmhouse Corp Competitors by Market Cap
The table below lists competitors of Pharmhouse Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Demco Public Company Limited
BK:DEMCO
|
$80.52 Million |
|
Jung Shing Wire Co Ltd
TW:1617
|
$80.54 Million |
|
Columbus Acquisition Corp Ordinary Shares
NASDAQ:COLA
|
$80.56 Million |
|
Berjaya Food Bhd
KLSE:5196
|
$80.58 Million |
|
Kootenay Silver Inc
V:KTN
|
$80.49 Million |
|
Canagold Resources Ltd
TO:CCM
|
$80.48 Million |
|
Holland Colours NV
AS:HOLCO
|
$80.47 Million |
|
Dagi Giyim Sanayi ve Ticaret AS
IS:DAGI
|
$80.45 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Pharmhouse Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -1,003,849 to 52,299,290, a change of 53,303,139.
- Net loss of 9,419,749 reduced equity.
- New share issuances of 306,600 increased equity.
- Other comprehensive income increased equity by 136,824.
- Other factors increased equity by 62,279,464.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-9.42 Million | -18.01% |
| Share Issuances | $306.60K | +0.59% |
| Other Comprehensive Income | $136.82K | +0.26% |
| Other Changes | $62.28 Million | +119.08% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Pharmhouse Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.46x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 35.35x to 1.46x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | $0.00 | $0.05 | x |
| 2014-12-31 | $0.00 | $0.05 | x |
| 2015-12-31 | $0.00 | $0.05 | x |
| 2017-12-31 | $0.00 | $0.05 | x |
| 2018-12-31 | $0.00 | $0.05 | x |
| 2019-12-31 | $0.00 | $0.05 | x |
| 2020-12-31 | $0.07 | $0.05 | x |
| 2021-12-31 | $0.07 | $0.05 | x |
| 2022-12-31 | $0.04 | $0.05 | x |
| 2023-12-31 | $0.00 | $0.05 | x |
| 2024-12-31 | $0.00 | $0.05 | x |
| 2025-12-31 | $0.03 | $0.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Pharmhouse Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -18.01%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -312.04%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 1.15x
- Recent ROE (-18.01%) is above the historical average (-65.30%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1996 | -13.83% | -7.20% | 1.04x | 1.85x | $-1.53 Million |
| 1997 | -85.72% | -21.58% | 1.62x | 2.45x | $-3.39 Million |
| 1998 | -637.14% | -43.02% | 2.45x | 6.04x | $-3.69 Million |
| 2014 | 14.91% | 6.65% | 0.40x | 5.57x | $0.49 |
| 2015 | -0.08% | -0.03% | 0.36x | 7.19x | $-571.04 |
| 2017 | 0.00% | -30.94% | 0.27x | 0.00x | $-373.00 |
| 2018 | 0.00% | -39.57% | 0.11x | 0.00x | $969.90 |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $574.30 |
| 2020 | -85.15% | 0.00% | 0.00x | 1.04x | $-6.06 Million |
| 2021 | -5.32% | 0.00% | 0.00x | 1.02x | $-992.13K |
| 2022 | -83.81% | 0.00% | 0.00x | 1.11x | $-3.30 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.31 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-676.69K |
| 2025 | -18.01% | -312.04% | 0.05x | 1.15x | $-14.65 Million |
Industry Comparison
This section compares Pharmhouse Corp's net assets metrics with peer companies in the Lodging industry.
Industry Context
- Industry: Lodging
- Average net assets among peers: $1,868,720,126
- Average return on equity (ROE) among peers: 4.89%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Pharmhouse Corp (PHSE) | $54.93 Million | -13.83% | 0.15x | $80.52 Million |
| Atour Lifestyle Holdings Limited American Depositary Shares (ATAT) | $1.19 Billion | 8.26% | 3.01x | $3.83 Billion |
| Choice Hotels International Inc (CHH) | $-23.51 Million | 0.00% | 0.00x | $4.94 Billion |
| Civeo Corp (CVEO) | $363.11 Million | 0.37% | 0.85x | $360.36 Million |
| GreenTree Hospitality Group Ltd (GHG) | $2.04 Billion | 4.34% | 1.28x | $76.39 Million |
| Hyatt Hotels Corporation (H) | $4.63 Billion | 7.43% | 0.76x | $7.14 Billion |
| Hilton Worldwide Holdings Inc (HLT) | $5.85 Billion | 5.78% | 3.48x | $72.11 Billion |
| Huazhu Group Ltd (HTHT) | $3.44 Billion | 12.69% | 1.24x | $13.13 Billion |
| The Intergroup Corporation (INTG) | $9.80 Million | 5.10% | 1.31x | $61.11 Million |
| Marriott International Inc (MAR) | $-682.00 Million | 0.00% | 0.00x | $98.31 Billion |
About Pharmhouse Corp
Pride Holdings Group operates as a LGBTQ-focused entertainment, hospitality, and lifestyle company in the United States. It engages in the bar, pub, tavern, restaurant, hotels, nightclubs, and live adult entertainment industry businesses. The company was formerly known as Parliament House Enterprises, Inc. and changed its name to Pride Holdings Group in July 2025. Pride Holdings Group is based in… Read more